What Is a 510(k)? FDA 510(k) Clearance, Submission, and Timelines Explained

2026-08-09 · Caduvo Team

A 510(k) premarket notification clears most Class II medical devices for U.S. sale by demonstrating substantial equivalence to a predicate. This guide walks through who needs one, what a submission includes, real timelines, and common pitfalls that trigger Additional Information requests.

You have a prototype. The device isn’t implantable, doesn’t sustain life, and the risk profile looks moderate. Your regulatory lead says you need a 510(k). But what is a 510(k) exactly — and what does the path actually demand?

A 510(k) is a premarket notification that clears a medical device for U.S. sale by showing it is substantially equivalent to a legally marketed device (a predicate). It is not product approval. Devices cleared under 510(k) receive a clearance letter, never an approval order. When you hear "FDA 510(k) clearance," that’s the precise term.

What Is a 510(k) and Who Needs One?

Most Class II devices — and a small subset of Class I devices that require premarket notification — use the 510(k) pathway. Low-risk Class I devices are typically exempt; high-risk Class III devices generally need a PMA. A quick classification check tells you if a 510(k) is mandatory. If you’re unsure where your device lands, the FDA medical device classification framework sorts devices into Class I, II, or III based on risk and intended use.

A 510(k) isn’t a prototype review. It’s a regulatory submission that compares your device to one already on the market. The central question: Does your device have the same intended use and technological characteristics, or are any differences acceptable because they don’t raise new safety or effectiveness questions? If the answer is yes, the device is substantially equivalent — the legal standard that drives the entire process.

Substantial Equivalence and the Predicate Device

You don’t prove your device is safe and effective from scratch. You prove it’s as safe and effective as a predicate. A predicate is a device that was legally marketed in the U.S. — usually cleared through a 510(k) itself — and has the same intended use. Your device can have different technological features as long as the differences don’t raise new questions of safety or effectiveness.

Choosing the right predicate is the most consequential decision in the submission. An overly aggressive predicate creates a mismatch that FDA will flag. A poorly documented predicate lengthens the review because the agency can’t verify performance data. We’ve written a practical guide on how to find and choose a predicate device that walks through the FDA databases, labeling comparisons, and documentation traps.

What’s Inside a 510(k) Submission?

A standard 510(k) submission includes roughly a dozen sections. Here’s what FDA expects, in order:

Some submissions also include clinical data, but fewer than 10% of 510(k)s do. If your device has new materials, new software algorithms, or different anatomical contacts, be prepared for benchtop and animal testing — and possibly a clinical study.

Realistic Timelines and Costs

FDA’s goal for a traditional 510(k) is a decision within 90 days. That clock starts once the submission passes a Refuse to Accept (RTA) review. RTA checks that all required elements are present; if not, the submission is rejected and you resubmit. In practice, from first submission to clearance, many 510(k)s take 5 to 8 months. FDA can pause the clock with an Additional Information (AI) request — effectively resetting the review timeline until you respond.

User fees for FY 2025 are $21,760 for a standard 510(k) and $5,440 for a small business. That’s just the filing fee. Add internal or consultant costs for compiling the submission, testing, and quality-system documentation, and total outlay often lands between $75,000 and $150,000 for a straightforward device — more if clinical data are required.

Common Pitfalls and FDA Additional Information Requests

AI requests are the largest driver of delay. Based on published FDA data, the top reasons 510(k)s get put on hold include:

  1. Predicate mismatch: The chosen predicate doesn’t share the same intended use or has different technological characteristics not adequately addressed.
  2. Inadequate performance testing: Missing test standards or failure to test worst-case scenarios.
  3. Labeling gaps: Instructions for use that contradict testing data or omit warnings.
  4. Software documentation: Incomplete software description per FDA’s software guidance.
  5. Electromagnetic compatibility: Insufficient testing per IEC 60601-1-2.

Pre-submission meetings (Q-Subs) with FDA can surface these issues early. A well-prepared Q-Sub package often prevents 2-3 rounds of AI letters.

Actionable Takeaways

Related reading